We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current BIS market cap is 4.57M. The company's latest EPS is USD -14.2683 and P/E is -1.31.
| Quarter End | |||||
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | |||||
| Operating Income | |||||
| Net Income |
| Year End 31 May 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 639k | 391k | 2k | 3k | 99k |
| Operating Income | 0 | 0 | 0 | 0 | 0 |
| Net Income | 1.19M | -14.02M | -4.48M | 1.85M | -3.51M |
| Quarter End | |||||
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | |||||
| Total Liabilities | |||||
| Total Equity |
| Year End 31 May 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 30.5M | 22.33M | 15.58M | 8.85M | 6.44M |
| Total Liabilities | 4.09M | 9.78M | 5.91M | 427k | 1.32M |
| Total Equity | 26.41M | 12.56M | 9.67M | 8.42M | 5.12M |
| Market Cap | 4.57M |
| Price to Earnings Ratio | -1.31 |
| Price to Sales Ratio | 46.37 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0.9 |
| Dividend Yield | - |
| Shares Outstanding | 246k |
| Average Volume (1 week) | 5.45k |
| Average Volume (1 Month) | 7.99k |
| 52 Week Change | -4.13% |
| 52 Week High | 26.51 |
| 52 Week Low | 16.37 |
| Spread (Intraday) | 1.02 (5.38%) |
| Company Name | ProShares UltraShort NASDAQ Biotechnology |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https:// |
| Industry | mgmt invt offices, open-end (6722) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
